Although we checked the effect of 2 HER2 inhibitors on tumor growth in vivo in HER2-overexpressed cervical cancer PDX models, since our cervical cancer PDX is treatment naïve, we suggest that cervical cancer PDXs would respond to cisplatin-based chemotherapy or radiation therapy. Here, ERBB2 is linked to neoplasm.